PTI Protherics

    RNS Number : 3391H
  Protherics PLC
  03 November 2008
   

    Protherics PLC

    Total Voting Rights and Share Capital


    London, UK; Brentwood, TN; 3 November 2008 - In conformity with the Transparency Directive,  Protherics PLC ("Protherics"), the
international biopharmaceutical company focused on critical care and cancer, notifies the market of the following:

    Protherics' issued share capital consists of 350,427,481 ordinary shares with a nominal value of 2 pence each, with voting rights.
Protherics does not hold any ordinary shares in Treasury.  Therefore, the total number of voting rights in Protherics is 350,427,481.

    The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required
to notify their interest in, or a change to their interest in, Protherics under the Financial Services Authority's Disclosure and
Transparency Rules.


    | Ends |



    For further information please contact:

 Protherics 
 Nick Staples, Director of Corporate Affairs  +44 (0) 7919 480510  
 Julie Vickers, Company Secretary             +44 (0)1928 518010

 Financial Dynamics - press enquiries
 London: Ben Atwell, Lara Mott                +44 (0) 20 7831 3113 
 New York: John Capodanno                     +1 212 850 5600

    Or visit  www.protherics.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
TVRFSAFMDSASEIF

Protherics (LSE:PTI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Protherics (LSE:PTI)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024